Amicus Therapeutics (FOLD) Has a Number of Key Catalysts Upcoming, Cowen Notes
Tweet Send to a Friend
Cowen analyst Ritu Baral reiterating an Outperform rating and $19 price target on Amicus Therapeutics (NASDAQ: FOLD) after updating their ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
